Product NDC: | 0591-3551 |
Proprietary Name: | Oxycodone and Aspirin |
Non Proprietary Name: | Oxycodone and Aspirin |
Active Ingredient(s): | 325; 4.8355 mg/1; mg/1 & nbsp; Oxycodone and Aspirin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-3551 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090084 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111018 |
Package NDC: | 0591-3551-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0591-3551-01) |
NDC Code | 0591-3551-01 |
Proprietary Name | Oxycodone and Aspirin |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0591-3551-01) |
Product NDC | 0591-3551 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxycodone and Aspirin |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111018 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | ASPIRIN; OXYCODONE HYDROCHLORIDE |
Strength Number | 325; 4.8355 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |